The Diabetes-Endocrinology Research Center (DERC) at the University of Massachusetts Medical Center (UMMC) is involved in studies related to the etiology, complications and treatment of diabetes and related endocrine disorders. The DERC is built on a research base of 28 funded investigators currently involved in diabetes-endocrinology related research. This Center substantially facilitates on-going studies and new projects and collaborations. There are three core laboratory facilities. A Protein Chemistry Core Facility is located in a laboratory newly constructed and equipped by UMMC. It provides substantial benefits to DERC investigators in sequencing of new hormones, hormone mediators, and receptors, including the insulin receptor. A Cell Science Core Facility is also located in a newly constructed and equipped interdepartmental laboratory. It is of great value in tissue culture, monoclonal antibody production, and cell sorting. A Morphology Core Facility has been organized which is based on existing laboratories in the Department of Pathology. It provides important capabilities including light microscopy, electron microscopy, morphometric analysis, radioautography, and immunocytochemistry. In addition to these core laboratory facilities, four pilot and feasibility studies are supported by the Center. These cover a broad range of areas including the autoimmune basis for diabetes in spontaneously diabetic BB/W rats, the biochemical basis for insulin action, and renal complications in diabetes. The Administrative structure includes a Director, Associate Director, seven member Executive Committee, and 12 member Advisory Committee. The latter includes six scientists from outside the UMMC facility. The Administrative Core also directs the Enrichment Program which includes lectures by five visiting scientists per year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK032520-05
Application #
3102012
Study Section
(SRC)
Project Start
1983-09-01
Project End
1988-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Desai, Paurav B; San Agustin, Jovenal T; Stuck, Michael W et al. (2018) Ift25 is not a cystic kidney disease gene but is required for early steps of kidney development. Mech Dev 151:10-17
Ly, Socheata; Navaroli, Deanna M; Didiot, Marie-Cécile et al. (2017) Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res 45:15-25
Wang, Feng; McCannell, Kurtis N; Boškovi?, Ana et al. (2017) Rlim-Dependent and -Independent Pathways for X Chromosome Inactivation in Female ESCs. Cell Rep 21:3691-3699
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210
LeBlanc, Scott E; Wu, Qiong; Lamba, Pallavi et al. (2016) Promoter-enhancer looping at the PPAR?2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucleic Acids Res 44:5133-47
Wang, Feng; Shin, JongDae; Shea, Jeremy M et al. (2016) Regulation of X-linked gene expression during early mouse development by Rlim. Elife 5:
Kincaid, Eleanor Z; Murata, Shigeo; Tanaka, Keiji et al. (2016) Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells. Nat Immunol 17:938-45
Townsley, E; O'Connor, G; Cosgrove, C et al. (2016) Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells. Clin Exp Immunol 183:419-30
Wyss, Lena; Stadinski, Brian D; King, Carolyn G et al. (2016) Affinity for self antigen selects Treg cells with distinct functional properties. Nat Immunol 17:1093-101
Delong, Thomas; Wiles, Timothy A; Baker, Rocky L et al. (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351:711-4

Showing the most recent 10 out of 707 publications